Q&A With Ludwig Kappos From University of Basel: Further Research Provides Positive Answers For Lingering Aubagio Questions

Recent research suggests that treatment with teriflunomide may slow brain atrophy in patients with relapsing multiple sclerosis.

With a condition as complicated as multiple sclerosis there are always going to be questions that need to be answered when it comes to patient care. One recent area of interest is preventing brain atrophy in this particular patient population.

Ludwig Kappos, MD, from the University of Basel in Switzerland discussed the results of this latest round of testing and what further tests could be conducted during the annual ECTRIMS congress in Barcelona.